|
LOC220930 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.19779749954796E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.56399371021143E-12 |
| Normal-vs-Stage2 |
1.577750E-04 |
| Normal-vs-Stage3 |
7.978900E-03 |
| Normal-vs-Stage4 |
1.391600E-02 |
| Stage1-vs-Stage2 |
5.420800E-01 |
| Stage1-vs-Stage3 |
1.117040E-01 |
| Stage1-vs-Stage4 |
9.685200E-01 |
| Stage2-vs-Stage3 |
4.768800E-01 |
| Stage2-vs-Stage4 |
6.840400E-01 |
| Stage3-vs-Stage4 |
3.898400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75475214756216E-12 |
| Normal-vs-AfricanAmerican |
2.69269995190058E-09 |
| Normal-vs-Asian |
2.109800E-01 |
| Caucasian-vs-AfricanAmerican |
6.803200E-01 |
| Caucasian-vs-Asian |
8.650200E-01 |
| AfricanAmerican-vs-Asian |
7.444600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5349501104065E-13 |
| Normal-vs-Female |
2.90430000049469E-08 |
| Male-vs-Female |
3.507800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.640520E-04 |
| Normal-vs-Extreme_Weight |
8.1776996285754E-10 |
| Normal-vs-Obese |
3.05949998669064E-09 |
| Normal-vs-Extreme_Obese |
2.641900E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.934200E-02 |
| Normal_Weight-vs-Obese |
1.622330E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.858800E-01 |
| Extreme_Weight-vs-Obese |
6.981400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.184800E-01 |
| Obese-vs-Extreme_Obese |
4.893800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.57659999999416E-05 |
| Normal-vs-Age(41-60Yrs) |
4.06230604710345E-13 |
| Normal-vs-Age(61-80Yrs) |
8.77960038003778E-10 |
| Normal-vs-Age(81-100Yrs) |
3.420500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.904000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.000400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.515500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.128100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.679200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.397170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.743700E-02 |
| Normal-VS-KIRP CIMP |
3.427500E-04 |
| Normal-VS-Unclassified PRCC |
2.1300000000446E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.98074889823374E-12 |
| Type1 PRCC-VS-KIRP CIMP |
8.384200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.626000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.429460E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
9.560900E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
1.077350E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.36080000000683E-05 |
| Normal-vs-N1 |
2.263600E-03 |
| Normal-vs-N2 |
6.704900E-03 |
| N0-vs-N1 |
8.299800E-01 |
| N0-vs-N2 |
6.923600E-01 |
| N1-vs-N2 |
9.346200E-01 |
|
|
